Trinity Biotech reported $19.16M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
EDAP TMS EUR 13.8M 1.73M Sep/2025
J&J USD 14.58B 392M Mar/2026
Mesa Laboratories USD 26.56M 1.18M Dec/2025
OraSure Technologies USD 30.31M 753K Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 11.1B 841M Dec/2025
Surmodics USD 15.17M 230K Sep/2024
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Tosoh JPY 248.86B 3.81B Sep/2025
Trinity Biotech USD 19.16M 210K Sep/2025
Veracyte USD 21.42M 870K Mar/2026